Delivery Order SPE2DB22D1202-SPE2DB25FUGA1
Award Date
10/21/24
Potential Completion Date
10/22/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,108.73 firm fixed-price delivery order contract is for the supply of Rexulti 1 mg tablets. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is a delivery order valued at $11,081.84 for the supply of the pharmaceutical product Rexulti 2 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has a period of performance through March 27, 2024. This delivery order is placed under a larger indefinite delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Rexulti 1 mg tablet in quantities of 30s. The award has a ceiling value of $4,457.98 and a completion date of August 27, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,606.39 firm fixed-price delivery order is for the supply of 4,566,121,371 units of the prescription drug Rexulti 2 mg tablet. The contract has an ultimate completion date of October 17, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Rexulti 0.5 mg tablets, a prescription medication, with an award value of $1,793.36 and a performance period through August 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award, valued at $15,064.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of the prescription medication Rexulti 1 mg tablet, with an ultimate completion date of May 6, 2025. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $32,326.93 firm-fixed-price delivery order is for REXULTI 2 MG tablets. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price valued at $10,748.27 and a completion date of June 6, 2025. The contract is for the supply of Rexulti 2 mg tablets, a prescription medication. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open...
This federal contract award, valued at $19,290.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,568,062,178 units of the prescription medication Rexulti 2 mg tablet. The contract has a firm fixed price and an ultimate completion date of April 29, 2025. This order is not set aside and appears to be part of a larger Indefinite Delivery...
This federal contract award, valued at $16,730.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Rexulti 0.5 mg tablet, with an ultimate completion date of April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...